AmgenvsQuidelOrtho

AMGN and QDEL stock compared: price, dividend, valuation and results, from SEC filings.

AMGN

Amgen Inc.

$441.69

Value $238B

-0.50%
AMGN's page

QDEL

QuidelOrtho Corporation

$9.60

Value $654M

+0.31%
QDEL's page

Amgen (AMGN) has a market value of $238B and QuidelOrtho (QDEL) $654M. Over the last year, with dividends, AMGN moved +31.9% and QDEL -54.9%. Dividend yield: AMGN 2.25%, QDEL none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AMGN$238B

    QDEL$654M

    AMGN is 364 times QDEL

  • Revenue, 12 months

    AMGN$38.9B

    QDEL$2.6B

    AMGN is 15 times QDEL

  • Net income, 12 months

    AMGN$9.4B

    QDEL-$369M

  • Operating margin

    AMGN32.4%

    QDEL-4.9%

    37.3 points apart

  • ROIC

    AMGN16.2%

    QDEL-2.2%

    18.4 points apart

  • P/E

    AMGN25.4

    QDEL–

  • Dividend yield

    AMGN2.3%

    QDEL0.0%

    2.3 points apart

  • 5-year return

    AMGN+150.8%

    QDEL-93.4%

    244.2 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AMGN+150.8%

QDEL-93.4%

010020020222023202420252026
Returns by period
PeriodAMGNWith dividendsQDELWith dividends
1 year since November 18, 2025+31.9%Price +28.4%-54.9%Price -54.9%
3 years since November 17, 2023+80.7%+21.8% a yearPrice +66.4%-85.5%-47.5% a yearPrice -85.5%
5 years since November 18, 2021+150.8%+20.2% a yearPrice +116.5%-93.4%-41.9% a yearPrice -93.4%
10 years since November 21, 2016+305.9%+15.0% a yearPrice +203.5%-58.2%-8.4% a yearPrice -58.2%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AMGNAmgenQDELQuidelOrtho

Valuation

AMGNQDEL
Valuation
Price$441.69$9.60
Market value$238B$654M
Enterprise value (EV)$279B$3.4B
P/E25.4–
P/E, 5-year median23.0–
P/B16.60.4
EV/EBIT22.1–
Free cash flow yield4.0%–

Results and growth

AMGNQDEL
Results and growth
Revenue, 12 months$38.9B$2.6B
Net income, 12 months$9.4B-$369M
Free cash flow, 12 months$9.6B-$117M
Earnings per share, 12 months$17.25-$5.39
Revenue growth, year on year10.0%-1.9%
Revenue growth a year, past+7.6%over 5 years+10.4%over 5 years
EPS growth a year, past+2.9%over 5 years–

Margins and returns on capital

AMGNQDEL
Margins and returns on capital
Gross margin70.9%44.2%
Operating margin32.4%-4.9%
Net margin24.1%-14.2%
ROIC16.2%-2.2%
ROE87.8%-19.7%

Balance sheet

AMGNQDEL
Balance sheet
Cash$13.2B$166M
Total debt$54.0B$3.1B
Net debt / EBITDA2.38.8
Interest cover4.8×-0.6×

Dividends and buybacks

AMGNQDEL
Dividends and buybacks
Dividend yield2.3%–
Dividend per share, 12 months$9.94–
Dividend growth a year, past+8.1%over 5 years–
Buyback yield––
Shareholder yield2.3%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AMGN or QDEL

Didn't find what you were looking for?

Ask us
Which is bigger, Amgen or QuidelOrtho?

By market value, Amgen ($238B) is about 364.3 times QuidelOrtho ($654M), at today's prices.

How did AMGN and QDEL stock do over the last 10 years?

Since November 21, 2016, AMGN's price moved +203.5% and QDEL's -58.2%. With dividends: AMGN +305.9% (+15.0% a year), QDEL -58.2% (-8.4% a year). Past returns do not predict future ones.

Which pays the higher dividend, AMGN or QDEL?

The dividend yield at today's price is 2.25% for Amgen and none for QuidelOrtho. Over the last twelve months they paid $9.94 and – per share.

Which has the higher profit margins, Amgen or QuidelOrtho?

Over the last twelve months, the net margin was 24.1% for Amgen and -14.2% for QuidelOrtho, and the operating margin 32.4% and -4.9%. Revenue was $38.9B and $2.6B.

Which is the better investment, Amgen or QuidelOrtho?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.